Autolus

Clinical-stage biopharmaceutical provider developing CAR T therapies for cancer and autoimmune diseases

placeLondon, England, United Kingdom calendar_todayFounded 2015 groups51 employees language autolus.com

Registered entities

Innovation

190 patent families (46 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 5,588 times.

YearFilings
20158
20167
201732
201847
201960
202072
202172
202248
202352
202445
202548
202611

Social engagement

Social engagement: 36.3K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Syncona; 1 has since exited.

Investor typeCountShare
Venture capital444%
Private equity333%
Other / undisclosed222%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

9 Aug 2024 · Director, Regulatory Affairs · null

Based on job postings tracked across public sources.

Recent activity

12 Jun 2026
Recognition
Coming soon